SLDB · Solid Biosciences Inc.
Market Cap
$1.05B
Shares
107.23M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-08-06 | — | |
| 8-K | 2026-06-10 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| DEF 14A | 2026-04-23 | 2026-06-10 | |
| 8-K | 2026-04-10 | — | |
| 10-K | 2026-03-19 | 2025-12-31 | |
| 8-K | 2026-03-12 | 2026-03-11 | |
| 8-K | 2026-03-06 | — | |
| 8-K | 2025-11-03 | — | |
| 10-Q | 2025-11-03 | 2025-09-30 | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-06-13 | 2025-06-12 | |
| 8-K | 2025-05-15 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| DEF 14A | 2025-04-25 | 2025-06-12 | |
| 10-K | 2025-03-06 | 2024-12-31 | |
| 8-K | 2025-02-18 | — | |
| 8-K | 2025-02-18 | — | |
| 8-K | 2025-02-18 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-06-11 | 2024-06-07 | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| DEF 14A | 2024-04-26 | 2024-06-11 | |
| 10-K | 2024-03-13 | 2023-12-31 | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-11-15 | 2023-11-14 | |
| 10-Q | 2023-11-08 | 2023-09-30 | |
| 10-Q | 2023-08-14 | 2023-06-30 | |
| 8-K | 2023-06-09 | 2023-06-06 | |
| 8-K | 2023-05-22 | — | |
| 10-Q | 2023-05-11 | 2023-03-31 | |
| DEF 14A | 2023-04-27 | 2023-06-06 | |
| 10-K | 2023-03-23 | 2022-12-31 | |
| 8-K | 2023-03-20 | 2023-03-19 | |
| 8-K | 2023-03-13 | — | |
| 8-K | 2023-01-09 | 2023-01-06 | |
| 8-K | 2022-12-05 | 2022-11-30 | |
| 8-K | 2022-12-01 | — | |
| 10-Q | 2022-11-10 | 2022-09-30 | |
| 8-K | 2022-10-27 | — | |
| 8-K | 2022-09-30 | — | |
| 8-K | 2022-09-30 | 2022-09-29 | |
| 8-K | 2022-08-11 | — | |
| 10-Q | 2022-08-11 | 2022-06-30 | |
| 8-K | 2022-06-09 | 2022-06-07 | |
| 8-K | 2022-06-06 | 2022-05-31 | |
| DEF 14A | 2022-04-28 | 2022-06-07 | |
| 10-Q | 2022-04-27 | 2022-03-31 |
Showing 1–50 of 89 filings
Key facts
CIK
1707502
CUSIP
83422E204
13F (30d)
141 filings
138 filers
Visit website
Investor relations